Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genocea Biosciences Inc (NASDAQ:GNCA)

4.06
Delayed Data
As of Jan 23
 -0.16 / -3.79%
Today’s Change
2.56
Today|||52-Week Range
8.07
-1.46%
Year-to-Date
No recent news for Genocea Biosciences Inc.

Today’s Trading

Previous close4.22
Today’s open4.19
Day’s range4.01 - 4.23
Volume209,861
Average volume (3 months)321,064
Market cap$119.8M
Dividend yield--
Data as of 01/23/2017

Growth & Valuation

Earnings growth (last year)+23.35%
Earnings growth (this year)+6.03%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales192.39
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
ADVMAdverum Biotechnolog...-0.05-1.69%
--Wang On Group Ltd0.000.00%
EVGNEvogene Ltd+0.02+0.39%
AUPHAurinia Pharmaceutic...+0.10+3.95%
Data as of 01/23/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$670.0K
Annual profit (last year)-$42.5M
Net profit margin-6,340.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William D. Clark
Chief Financial Officer &
Head-Investor Relations
Jonathan Michael Poole
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs